Brief: Bioporto Plans Clinical Evaluation Of Test For Rapid Detection Of Covid-19 Virus

BioPorto A/S

17/09/2020 08:46

Sept 17 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * REG-BIOPORTO PLANS INITIAL CLINICAL EVALUATION OF
GRAD-BASED
TEST FOR RAPID DETECTION OF COVID-19 VIRUS
    * PRELIMINARY ANALYTICAL STUDIES OF NEWLY CREATED SARS-COV-2
ANTIBODIES, FOR DETECTION OF ACTIVE VIRUS, HAVE SHOWN PROMISING
RESULTS IN TESTING AGAINST HEAT-INACTIVATED VIRUS
    * INTENDS TO REQUEST AN EMERGENCY USE AUTHORIZATION (EUA)
FROM US
FOOD AND DRUG ADMINISTRATION (FDA) AND TO APPLY FOR CE MARK,
WHICH COULD LEAD TO PRODUCT LAUNCH BEFORE END OF YEAR.
    * ANNOUNCEMENT DOES NOT ALTER BIOPORTO'S FINANCIAL GUIDANCE
FOR
2020

Source text for Eikon:  ID:nGNEb5RDXy 
Further company coverage:  BIOPOR.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))